Immunohistochemistry analysis of tumor cells and TIL samples from 123 untreated DLBCL patients indicated that TIM-3 was highly expressed in DLBCL tumor cells, and more than one-third of patients (39%) also exhibited TIM-3 expression in TILs. Here, HAVCR2 is linked to diffuse large B-cell lymphoma.